DOI: 10.12890/2025_005336
Haemophagocytic lymphohistiocytosis as an initial presentation of undiagnosed systemic lupus erythematosus
Authors
lujainkmg@gmail.com
Keywords
Haemophagocytic lymphohistiocytosis, macrophage activation syndrome, systemic lupus erythematosus, neuropsychiatric SLE, hyperferritinaemiaAbstract
Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal hyperinflammatory syndrome with multi-organ involvement. It may occur secondary to autoimmune diseases such as systemic lupus erythematosus (SLE).
Case description: This report describes an unusual case of a previously healthy 29-year-old female medical student who presented with a one-month history of recurrent fever, fatigue and significant weight loss. Initial laboratory investigations revealed pancytopaenia, hyperferritinaemia and hypertriglyceridaemia. Infectious disease workup was negative. Serological testing demonstrated positive antinuclear antibody and anti-double-stranded DNA antibodies, while bone marrow biopsy confirmed haemophagocytosis. The patient was diagnosed with secondary HLH due to SLE. During treatment in the intensive care unit, the patient developed psychosis manifested by visual hallucinations and mood swings. A diagnosis of neuropsychiatric SLE was confirmed by exclusion of other causes (e.g. steroid therapy) and the presence of non-specific white matter hyperintensities on brain magnetic resonance imaging. Combination therapy with high-dose corticosteroids, intravenous immunoglobulin and rituximab resulted in significant clinical and laboratory improvements within two weeks.
Conclusion: This case illustrates how HLH can be the initial manifestation of previously undiagnosed SLE. Hence, clinicians should maintain a high index of suspicion for underlying autoimmune disorders such as SLE when evaluating patients with HLH, as early recognition and appropriate immunosuppressive therapy are crucial for optimal outcomes.
References
- Hutchinson M, Tattersall RS, Manson JJ. Haemophagocytic lymphohisticytosis – an underrecognized hyperinflammatory syndrome. Rheumatology (Oxford) 2019;58:vi23–vi30.
- Yang S, Zhao M, Jia S. Macrophage: key player in the pathogenesis of autoimmune diseases. Front Immunol 2023;14:1080310.
- Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 2020;34:101515.
- Gupta D, Mohanty S, Thakral D, Bagga A, Wig N, Mitra DK. Unusual association of hemophagocytic lymphohistiocytosis in systemic lupus erythematosus: cases reported at tertiary care center. Am J Case Rep 2016;17:739–744.
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019,71:1400–1412.
- Henter JI, Sieni E, Eriksson J, Bergsten E, Hed Myrberg I, Canna SW, et al. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Blood 2024;144:2308–2318.
- Ali R, Mehannek R, Patel A, Paige A, Reddy S, Guma M, et al. Systemic lupus erythematosus with hemophagocytic lymphohistiocytosis: is COVID-19 the inciting factor? Cureus 2021;13:e19657.
- So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus. Mod Rheumatol 2014;24:855–857.
- Kumakura S, Murakawa Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol 2014;66:2297–2307.
- Porel R, Kumar V, Agarwal K, Biswas R, Ojha VS. Secondary hemophagocytic lymphohistiocytosis: a series of three cases. Cureus 2023;15:e46044.
